Hyperprogressive disease in lung metastases without target lesion progression after durvalumab consolidation therapy: A case report

Abstract Hyperprogressive disease (HPD) is a novel progressive pattern that occurs after immune checkpoint inhibitor (ICI) administration. Here, a 74‐year‐old woman who had undergone right lower lobectomy for lung cancer received curative chemoradiotherapy followed by consolidation therapy with durv...

Full description

Bibliographic Details

Published in:	Thoracic Cancer
Main Authors:	Kosuke Masuda, Yoshiaki Nagai, Hikari Amari, Hiroki Tahara, Yuki Maeda, Jun Shiihara, Hiromitsu Ohta, Masahiro Hiruta, Yasuhiro Yamaguchi
Format:	Article
Language:	English
Published:	Wiley 2023-11-01
Subjects:	hyperprogressive disease immune checkpoint inhibitor lung cancer
Online Access:	https://doi.org/10.1111/1759-7714.15104